Biodefense vaccines

Published on October 29, 2009 Reviewed on November 18, 2016   41 min

Other Talks in the Series: Molecular Basis of Bacterial Infection

This is James Nataro, University of Maryland School of Medicine, Center for Vaccine Development. We are going to talk for a few minutes about category A biodefense vaccines. Talk a bit about considerations and development of vaccines, and the status of some of the vaccines that are available or new development. The NIH has defined certain pathogens as what they call Category A threats.
And these agents have been selected on the basis of several criteria. So, all of them first of all would cause very very severe potentially lethal infections, and secondly they can be delivered by highly efficient routes. That is they can be released into the air, or they can be inoculated into food or water. But all of them have a potential for severe, highly lethal infections that can be efficiently disseminated among large portions of the population.